Antibody response after a booster dose of SARS-CoV-2 vaccine in liver transplant recipients and those with chronic liver diseases.

Ann Hepatol · 2022 · PMC8942457 · PMID 35338012

Europe PMC DOI

hedged sentence

0.0001

closest p · 0.0× alpha

0.0001

boldest claim

The sentences

highly significantp=0.0001actually significant

The difference in response after booster dose between the undetectable and low Ab group was highly significant (42% vs. 87%, p=0.0001).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.